425 related articles for article (PubMed ID: 32907554)
1. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan and kynurenine stimulate human decidualization via activating Aryl hydrocarbon receptor: Short title: Kynurenine action on human decidualization.
Wang PC; Chen ST; Hong ZK; Li SY; Yang ZS; Quan S; Yang ZM
Reprod Toxicol; 2020 Sep; 96():282-292. PubMed ID: 32781018
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.
Moyer BJ; Rojas IY; Murray IA; Lee S; Hazlett HF; Perdew GH; Tomlinson CR
Toxicol Appl Pharmacol; 2017 May; 323():74-80. PubMed ID: 28336214
[TBL] [Abstract][Full Text] [Related]
5. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition.
Dos Santos IL; Mitchell M; Nogueira PAS; Lafita-Navarro MC; Perez-Castro L; Eriom J; Kilgore JA; Williams NS; Guo L; Xu L; Conacci-Sorrell M
FEBS J; 2024 May; 291(10):2172-2190. PubMed ID: 38431776
[TBL] [Abstract][Full Text] [Related]
6. Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy.
Ogura J; Miyauchi S; Shimono K; Yang S; Gonchigar S; Ganapathy V; Bhutia YD
Biochem J; 2017 Sep; 474(20):3391-3402. PubMed ID: 28963435
[TBL] [Abstract][Full Text] [Related]
7. Amyloid β neurotoxicity is IDO1-Kyn-AhR dependent and blocked by IDO1 inhibitor.
Duan Z; Zhang S; Liang H; Xing Z; Guo L; Shi L; Du L; Kuang C; Takikawa O; Yang Q
Signal Transduct Target Ther; 2020 Jun; 5(1):96. PubMed ID: 32532956
[No Abstract] [Full Text] [Related]
8. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
Labadie BW; Bao R; Luke JJ
Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Bhutia YD; Babu E; Ganapathy V
Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
[TBL] [Abstract][Full Text] [Related]
11. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
Turski WA; Wnorowski A; Turski GN; Turski CA; Turski L
Restor Neurol Neurosci; 2020; 38(4):343-354. PubMed ID: 32597823
[TBL] [Abstract][Full Text] [Related]
12. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
[TBL] [Abstract][Full Text] [Related]
13. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
Zajda K; Ptak A; Rak A; Fiedor E; Grochowalski A; Milewicz T; Gregoraszczuk EL
Toxicology; 2017 Aug; 389():1-12. PubMed ID: 28710019
[TBL] [Abstract][Full Text] [Related]
14. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
15. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.
Kim CE; Lee SM; Yoon EH; Won HJ; Jung YJ; Jegal Y; Kim DH; Kwon B; Seo SK
Int Immunopharmacol; 2024 Jun; 134():112246. PubMed ID: 38759372
[TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
17. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of endurance training and nettle leaf extract on the IDO1-KYN-AHR pathway homeostasis and inhibiting of liver toxicity in rats with STZ-induced diabetes.
Haghshenas R; Aftabi Y; Doaei S; Gholamalizadeh M
Front Endocrinol (Lausanne); 2023; 14():1071424. PubMed ID: 37305057
[TBL] [Abstract][Full Text] [Related]
19. Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
Alvarado DM; Chen B; Iticovici M; Thaker AI; Dai N; VanDussen KL; Shaikh N; Lim CK; Guillemin GJ; Tarr PI; Ciorba MA
Gastroenterology; 2019 Oct; 157(4):1093-1108.e11. PubMed ID: 31325428
[TBL] [Abstract][Full Text] [Related]
20. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
